Given the reported critical role of Toll‐like receptors in recognizing H. pylori during infection, the usa of CpG adjuvant can better mimic the pro‐inflammatory process triggered by TLR9‐mediated bacterial DNA recognition in human hosts.[55, 56] Our results demonstrated the practical potential of combining synthetic peptides with CpG in future vaccine development. This evidence concerns the gene TLR9 and infection.